Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 1/20 | 0.64 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4063843 | 0.94 | HSPA5 (0.73) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL30874252 | 0.89 | HSPA5 (0.80) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL5852506 | 0.89 | HSPA5 (0.80) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL54577 | 0.89 | HSPA5 (0.80) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL9063157 | 0.87 | HSPA5 (0.76) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL8583175 | 0.83 | HSPA5 (0.76) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL11686142 | 0.82 | HSPA5 (0.67) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL14595234 | 0.82 | HSPA5 (0.67) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL4062308 | 0.82 | HSPA5 (0.67) | HSPA5KEAP1CYP2D6TSHRHIF1A | |
| SCHEMBL49745 | 0.80 | HSPA5 (1.00) | HSPA5KEAP1CYP2D6TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | HSPA5 4266/4885KEAP1 1098/4885CYP2D6 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.